TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HIBROW HLTHCARE

NeurologyCardiovascularOphthalmology
Generics

HIBROW HLTHCARE is a generic drug manufacturer focused on Neurology, Cardiovascular, Ophthalmology. Key products include LABETALOL HYDROCHLORIDE.

2016
Since
18
Drugs
-
Trials
414
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

FLUDROCORTISONE ACETATE 2026-02-10
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
ACETAZOLAMIDE 2026-01-12
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
2 drugs
Cardiovascular 20%
1 drugs
Ophthalmology 20%
1 drugs
Metabolic 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology, Metabolic
B BRAUN specialty
Ophthalmology, Metabolic, Cardiovascular
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Neurology
Novartis big-pharma
Cardiovascular, Ophthalmology